Brokerages Anticipate Inspire Medical Systems (INSP) to Announce ($0.46) Earnings Per Share

Inspire Medical Systems (NASDAQ:INSP) has been assigned a consensus broker rating score of 1.50 (Buy) from the four analysts that provide coverage for the stock, Zacks Investment Research reports. One analyst has rated the stock with a hold rating and three have given a strong buy rating to the company.

Analysts have set a one year consensus price objective of $39.00 for the company and are predicting that the company will post ($0.46) earnings per share for the current quarter, according to Zacks. Zacks has also given Inspire Medical Systems an industry rank of 58 out of 255 based on the ratings given to related companies.

INSP has been the subject of a number of analyst reports. Bank of America initiated coverage on Inspire Medical Systems in a research report on Tuesday, May 29th. They set a “neutral” rating and a $36.00 price objective for the company. Guggenheim initiated coverage on Inspire Medical Systems in a research report on Tuesday, May 29th. They set a “buy” rating and a $40.00 price objective for the company. Goldman Sachs Group began coverage on Inspire Medical Systems in a research report on Tuesday, May 29th. They set a “neutral” rating and a $25.00 price objective for the company. Wells Fargo & Co began coverage on Inspire Medical Systems in a report on Tuesday, May 29th. They issued an “outperform” rating and a $38.00 price target for the company. Finally, Stifel Nicolaus began coverage on Inspire Medical Systems in a report on Tuesday, May 29th. They issued a “buy” rating and a $42.00 price target for the company.



Shares of Inspire Medical Systems stock traded up $2.48 on Thursday, reaching $37.66. 244,800 shares of the company were exchanged, compared to its average volume of 229,681. Inspire Medical Systems has a 1-year low of $22.50 and a 1-year high of $41.01.

In other Inspire Medical Systems news, CFO Richard Buchholz purchased 4,750 shares of the stock in a transaction that occurred on Monday, May 7th. The stock was purchased at an average cost of $16.00 per share, with a total value of $76,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Marilyn C. Nelson purchased 62,500 shares of the stock in a transaction that occurred on Monday, May 7th. The stock was acquired at an average cost of $16.00 per share, with a total value of $1,000,000.00. The disclosure for this purchase can be found here. Insiders purchased 195,550 shares of company stock valued at $3,128,800 over the last ninety days.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Get a free copy of the Zacks research report on Inspire Medical Systems (INSP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Inspire Medical Systems (NASDAQ:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply